Company Deep Dive

Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.

View Deep Dive

H02.SI

HoldFallen Favourite

Haw Par Corporation Limited · Healthcare · Singapore · $2.6B · Avg Vol: $3M/d

58
StockRank
Get insider-trade alerts
Q
59
V
47
M
47
P/E (TTM)
13.6x
ROE
5.2%
D/E
0.0x
Dividend %
2.9%
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Haw Par Corporation Limited is a Singaporean conglomerate with diversified interests in healthcare, primarily through its globally recognized Tiger Balm brand, as well as leisure operations and strategic investments. The company's competitive advantage is rooted in the enduring strength of the Tiger Balm brand, which boasts widespread international recognition and loyalty. Haw Par leverages this core asset alongside its diversified portfolio to generate stable returns across various economic cycles.

FINANCIAL SUMMARY (SGD)

Year20212022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue—182.1M232.1M244.8M230.0M8.1%219.4M216.7M221.7M-1.8%
EPS (SGD)0.500.670.981.031.2024.6%1.031.021.12-3.3%
Shares—221.4M221.4M221.4M221.4M+0.0%221.4M———
Debt—29.2M28.5M36.8M44.7M15.2%52.6M———
Equity—3.5B3.5B4.1B4.3B6.5%————
Op CF—40.9M62.7M53.8M57.1M11.7%51.9M———
Inv CF—-261.6M258.0M199.8M292.8M—————
Fin CF—-38.1M-79.3M-82.8M-302.4M—————
Loading 1Y...
PRICE (1Y)-14.1%
10.8311.3411.8512.3612.87Jul 28Aug 19Sep 9
SMA 50SMA 200

Close
$10.83
RSI (14)
13.6
52W High
$14.08
From 52W High
0.8%

SCORE BREAKDOWN

Quality
59
ROIC
6.5%63.5
ROE
5.2%59.1
GP/Assets
2.8%16.6
Op. Margin
28.0%90.6
FCF/Assets
1.0%51.0
Piotroski
560.9
Int. Cover
50.0x89.4
D/E Ratio
0.01x83.7
Current Ratio
5.57x73.6
Value
47
P/E (TTM)
13.6x76.9
EV/EBITDA
34.3x17.4
P/FCF
74.8x19.9
P/B
0.7x93.5
P/S
14.1x21.8
Div Yield
2.9%65.6
Momentum
47
52W High %
77%64.5
RS 6M
-29%33.4
SMA 50/200
0.98x53.8
EPS Rev 4W
+2.0%65.8
EPS Rev 12W
+0.7%48.5
EPS Improve
+24%38.5
Q Growth
-25%20.5

FUNDAMENTALS

Market Cap
$2.6B
P/E (Forward)
10.9x
Gross Margin
55.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of H02.SI are excluded.

TickerCompanyMkt CapStockRankSignal
H02.SIHaw Par Corporation Limited(you)$2.6B58Hold
FHH.SIFoundation Healthcare Holdings Limited$751M58Hold
BSL.SIRaffles Medical Group Ltd$1.2B77Buy
QC7.SIQ & M Dental Group (Singapore) Limited$402M61Hold
A50.SIThomson Medical Group Limited$1.1B27Sell
ULG.SIUltraGreen.ai Limited$771M89Strong Buy
AP4.SIRiverstone Holdings Limited$901M94Strong Buy
42C.SIiX Biopharma Ltd.$347M35Hold
1D4.SIAoxin Q & M Dental Group Limited$196M39Hold
2629.HKMirxes Holding Company Limited$472M21Sell

Peer medians: ROE 1.2% · P/E 21.4x · Gross margin 41.1%

Haw Par Corporation Limited (H02.SI): Stock Score Summary

Haw Par Corporation Limited (H02.SI) has a MoatMap StockRank of 58/100 based on Quality (59/100), Value (47/100), and Momentum (47/100) factor scores. The current signal is HOLD.

Haw Par Corporation Limited is a Singaporean conglomerate with diversified interests in healthcare, primarily through its globally recognized Tiger Balm brand, as well as leisure operations and strategic investments. The company's competitive advantage is rooted in the enduring strength of the Tiger Balm brand, which boasts widespread international recognition and loyalty. Haw Par leverages this core asset alongside its diversified portfolio to generate stable returns across various economic cycles.

Key Financial Metrics

Price$10.83
Market Cap$2.6B
P/E (TTM)13.61
P/E (Forward)10.93
Price/Book0.65
Return on Equity5.2%
Return on Invested Capital6.5%
Debt/Equity0.01x
Gross Margin55.5%
Operating Margin28.0%
Revenue Growth-8.2%
Dividend Yield2.9%
Free Cash Flow$34M

Haw Par Corporation Limited operates in the Drug Manufacturers - General industry, part of the Healthcare sector (Singapore).

Frequently Asked Questions

What is Haw Par Corporation Limited’s (H02.SI) StockRank?
MoatMap’s StockRank for Haw Par Corporation Limited (H02.SI) is 58/100, with a Hold signal. It is a composite of Quality (59), Value (47), and Momentum (47) factor ranks across MoatMap’s 20,000+ stock universe.
Does Haw Par Corporation Limited have an economic moat?
Haw Par Corporation Limited (H02.SI) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Haw Par Corporation Limited a buy, hold, or sell?
MoatMap’s current signal for Haw Par Corporation Limited (H02.SI) is Hold, based on a StockRank of 58/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Haw Par Corporation Limited in?
Haw Par Corporation Limited (H02.SI) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (Singapore).
Browse all ranked stocksH02.SI deep dive reportAI ChampionsHow we score stocksSense-check another stock
Featured essay

Haw Par (H02.SI): A $3B Singapore Conglomerate Where the Market Prices Tiger Balm at Less Than Zero

Add up Haw Par's UOB and UOL shares, net cash and property and you get $3.35B, more than the whole $3B company. So the market prices Tiger Balm, a 117-year-old global brand, at less than zero. The Wee family cross-holdings, a succession catalyst, StockRank 80.

8 min readRead the essay →